Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-06-07
2000-08-22
Huang, Evelyn Mei
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514250, 514257, 514293, 514287, 544233, 544245, 544247, 544343, 546 15, 546 41, 546 48, 546 64, 546 65, 546 83, A61K 31437, C07D49514, C07D49522
Patent
active
061073040
ABSTRACT:
Invented are substituted thieno (2,3-b)pyrazolo(3,4-d)pyridin-3-ones, pharmaceutical compositions containing these compounds, and methods of using these compounds to enhance erythropoiesis. Also invented are intermediates and processess used in preparing these compounds.
REFERENCES:
Kahn et al., J. Heterocyclic Chem., vol. 20, pp. 475-476 (Mar.-Apr. 1983).
Chemical Abstracts, vol. 89, No. 15, Abstract No. 129437q, p. 585 (Oct. 9, 1978).
Huang Evelyn Mei
Kanagy James M.
Kinzig Charles M.
SmithKline Beecham Corporation
LandOfFree
Thieno[2,3-b]pyrazolo[3,4-d]pyridine-3-ones to enhance erythropo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thieno[2,3-b]pyrazolo[3,4-d]pyridine-3-ones to enhance erythropo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thieno[2,3-b]pyrazolo[3,4-d]pyridine-3-ones to enhance erythropo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581402